|

Aromatase Inhibitor Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: AI, Anastrozole (Arimidex), Exemestane (Aromasin), Letrozole (Femara)

Other2 trials

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Phase 3
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Phase 2

Pittsburgh, Pennsylvania1 trial

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

UPMC Magee Womens Hospital

Phase 1

Austin, Texas1 trial

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Next Oncology Austin

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.